Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4805999
Reference Type
Journal Article
Title
Biocompatibility and hemocompatibility evaluation of polyether urethanes synthesized using DBU organocatalyst
Author(s)
Basterretxea, A; Haga, Y; Sanchez-Sanchez, Ana; Isik, M; Irusta, L; Tanaka, M; Fukushima, K; Sardon, H
Year
2016
Is Peer Reviewed?
Yes
Journal
European Polymer Journal
ISSN:
0014-3057
Volume
84
Page Numbers
750-758
DOI
10.1016/j.eurpolymj.2016.08.008
Web of Science Id
WOS:000390181800061
Abstract
Biomaterials must fulfill some requirements before moving into in vivo application. In vitro test is usually conducted as a preliminary screening evaluation. Although most of the studies are focused in the cytotoxicity, interactions between blood elements and the bio-materials or hemocompatibility must also be considered. Aliphatic polyurethanes have been always considered ideal candidates for in-vivo application due to their versatility. However, the utilization of metal catalyst to promote the polymerization have limited their use. Recently, some organocatalysts have shown to be competitive to tin based catalyst for the preparation of polyurethanes and have relaunched their use in biomedicine. In the present study we carried out the organocatalyzed polymerization of 5 commercially available isocyanates, hexamethylene diisocyanate, isophorone diisocyanate, trans-1,4-cyclohexylene diisocyanate, 4,4'-methylenebis(cyclohexyl isocyanate) and L-lysine diisocyanate to analyze the cytotoxicity and hemocompatibility of the resultant polymers as a function of the employed diisocyanate. The diisocyanates were polymerized with hydroxy end-capped oligomeric poly (tetramethylene glycol) (PT2K) as the long chain diol and 1,3-propanediol as the short chain diol. We demonstrated that from selected diisocyanates, lysine diisocyanate based polyurethanes possessed lower cytotoxicity and better hemocompatibility than the other polyurethanes. In comparison with a well known blood compatible polymer such as poly(2-methoxyethyl acrylate), the lysine diisocyanate based polyurethanes showed remarkable values in terms of cytotoxicity and platelet adhesion, but major levels of protein adsorption. (C) 2016 Elsevier Ltd. All rights reserved.
Keywords
Polyurethanes; Organocatalysis; Hemocompatibility; Biocompatibility; Lysine diisocyanate
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity